Why Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) Holds All the Cards


Auxly Cannabis Group Inc (OTCMKTS: CBWTF) is one of the biggest cannabis producers in the world that has not seen the type of recognition of say Aphria or Canopy. The stock has quickly attracted a large shareholder base who believes this one goes way higher.

Auxly Cannabis is quickly establishing itself as a major player in the booming cannabis space responsible for many, many huge recent winners. The sector is on fire as we near legal recreational cannabis in Canada on October 17. The global legal marijuana market is expected to reach USD 146.4 billion by end of 2025, according to a new report by Grand View Research, Inc.

Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) is a vertically integrated cannabis company currently sitting on a war chest of $295 million. The Company’s vision is to become the first and foremost streaming enterprise in the cannabis industry and to provide alternative financing solutions for smaller licensed producers. Auxly is the brainchild of Chuck Rifici – ‘Godfather of Canadian weed’ founder of Canopy Growth, former CEO of Tweed Marijuana Inc, and former CFO of the Liberal Party of Canada. Chuck did a great AMA recently on reddit you can find it here.

Auxly currently has licensing and streaming deals with at least 15 licensed producers listed here. Looking at the production numbers Auxly is well on their way to being one of the biggest cannabis producers on the planet.

The Company also has an 80% stake in Montevideo, Uruguay based Inverell, a federally licensed “Cannabis Operator” for the large-scale outdoor production of hemp plants for CBD extraction. Led by a seasoned operator, Dr Raul Urbina, founder and CEO of Stevia One, that became one of the lowest cost producers of stevia in the world. Inverell has 16 hectares of plants in the ground with expansion capacity for an additional 574 hectares.

Inverell gives Auxly a diversified source of low-cost CBD production for the Company’s international distribution channels. It also gives Auxly a foothold in the Uruguays cannabis market which aims to be a dominate player globally.

Chuck Rifici commented “Uruguay wants to be a cannabis leader so I’m really excited about the long term prospects for Uruguay as a center for production of all cannabanoids at incredibly low cost for export internationally. I think that will be a key piece of our platform as the years unfold.

Earlier this year Auxly acquired Dosecann Inc. a late-stage “Licensed Dealer” applicant pursuant to the Narcotic Control Regulations. Located in the biotech hub of Charlottetown, Prince Edward Island, Dosecann is currently completing the buildout of a 42,000 square foot facility, purpose-built for the research, development, extraction, formulation, filling and packaging of cannabis-based products. Upon receipt of regulatory approval, Dosecann will leverage its state-of-the-art facility to begin developing a range of value added cannabis-based products for the Company and its streaming partners to ultimately be sold to medical cannabis patients and, upon approval, into the natural health product and adult-use cannabis markets.

To Find out the inside Scoop on Auxly Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Last month Auxly announced a strategic investment and commercial rights agreement with Kaneh Bosm. The Transaction provides Auxly access to a significant and established portfolio of international cannabis licenses, assets and distribution networks. As a result of the Transaction, Auxley believes that it has substantially accelerated its entry into numerous international cannabis markets and partnered with an ambitious team focused on future growth. As part of the transaction, Kaneh Bosm changed its name to ICC International Cannabis Corp.

Kaneh Bosm, through its subsidiaries, has a number of agreements and licenses in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licenses in Greece and wholly-owned licenses to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark. In addition, Kaneh Bosm is actively pursuing further cannabis licenses and related infrastructure in other international jurisdictions where cannabis is legal for medical or non-medical purposes. Kaneh Bosm intends to use the net proceeds from the Investment to begin its growth and development under the strategic alliance with Auxly, as well as for working capital and general corporate purposes.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $490 million market valuation Auxly is sitting on a war chest of $295 million, and is debt free. Led by cannabis visionary Chuck Rifici, Auxly has quickly attracted a leadership team of industry first movers, enterprising visionaries and deep-experience specialists. Auxly has licensing and streaming deals in place with at least 15 licensed producers and is well on their way to being one of the biggest cannabis producers on the planet. We will be updating on Auxly when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Auxly.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in Auxly either long or short and we have not been compensated for this article.


Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.